 Connection
Michael Yaron to Saliva
This is a "connection" page, showing publications Michael Yaron has written about Saliva.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.798 |
|
|
|
-
Tishler M, Yaron I, Shirazi I, Levartovsky D, Yaron M. Salivary and serum soluble interleukin-2 receptor in primary Sjögren's syndrome. Arch Oral Biol. 1999 Apr; 44(4):305-8.
Score: 0.134
-
Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis. 1999 Apr; 58(4):253-6.
Score: 0.134
-
Tishler M, Yaron I, Shirazi I, Yossipov Y, Yaron M. Increased salivary interleukin-6 levels in patients with primary Sjögren's syndrome. Rheumatol Int. 1999; 18(4):125-7.
Score: 0.132
-
Tishler M, Yaron I, Shirazi I, Yaron M. Salivary and serum hyaluronic acid concentrations in patients with Sjögren's syndrome. Ann Rheum Dis. 1998 Aug; 57(8):506-8.
Score: 0.128
-
Tishler M, Yaron I, Shirazi I, Yaron M. Saliva: an additional diagnostic tool in Sjögren's syndrome. Semin Arthritis Rheum. 1997 Dec; 27(3):173-9.
Score: 0.122
-
Tishler M, Yaron I, Raz A, Meyer FA, Yaron M. Salivary eicosanoid concentration in patients with Sjögren's syndrome. Ann Rheum Dis. 1996 Mar; 55(3):202-4.
Score: 0.108
-
Tishler M, Yaron I, Shirazi I, Yaron M. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease. J Rheumatol. 2001 Apr; 28(4):795-7.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|